These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38065676)

  • 1. Prediction value of neutrophil and eosinophil count at risk of COPD exacerbation.
    Chen TT; Lee KY; Chang JH; Chung CL; Tran HM; Manullang A; Ho SC; Chen KY; Tseng CH; Wu SM; Chuang HC
    Ann Med; 2023; 55(2):2285924. PubMed ID: 38065676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between eosinophilic exacerbation and eosinophilic levels in stable COPD.
    Kang HS; Kim SK; Kim YH; Kim JW; Lee SH; Yoon HK; Rhee CK
    BMC Pulm Med; 2021 Mar; 21(1):74. PubMed ID: 33653314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood cell for the differentiation of airway inflammatory phenotypes in COPD exacerbations.
    Gao J; Chen B; Wu S; Wu F
    BMC Pulm Med; 2020 Feb; 20(1):50. PubMed ID: 32093672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophilic and non-eosinophilic COPD patients with chronic respiratory failure: neutrophil-to-lymphocyte ratio as an exacerbation marker.
    Acartürk Tunçay E; Karakurt Z; Aksoy E; Saltürk C; Gungor S; Ciftaslan N; Irmak İ; Yavuz D; Ocakli B; Adıgüzel N
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3361-3370. PubMed ID: 29200843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of Blood Eosinophil Count to Exacerbations in Chronic Obstructive Pulmonary Disease.
    Zeiger RS; Tran TN; Butler RK; Schatz M; Li Q; Khatry DB; Martin U; Kawatkar AA; Chen W
    J Allergy Clin Immunol Pract; 2018; 6(3):944-954.e5. PubMed ID: 29153881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressor of variegation 3-9 homologue 1 impairment and neutrophil-skewed systemic inflammation are associated with comorbidities in COPD.
    Chen TT; Wu SM; Chen KY; Tseng CH; Ho SC; Chuang HC; Feng PH; Liu WT; Han CL; Huang EW; Yeh YK; Lee KY
    BMC Pulm Med; 2021 Oct; 21(1):276. PubMed ID: 34598691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood Eosinophil Count as a Predictive Biomarker of Chronic Obstructive Pulmonary Disease Exacerbation in a Real-World Setting.
    Komura M; Sato T; Suzuki Y; Yoshikawa H; Nitta NA; Hayashi M; Kuwasaki E; Horikoshi K; Nishioki T; Mori M; Kodama Y; Sasaki S; Takahashi K
    Can Respir J; 2023; 2023():3302405. PubMed ID: 37275320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia.
    Duman D; Aksoy E; Agca MC; Kocak ND; Ozmen I; Akturk UA; Gungor S; Tepetam FM; Eroglu SA; Oztas S; Karakurt Z
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2469-78. PubMed ID: 26648709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does eosinophilia and neutrophil to lymphocyte ratio affect hospital re-admission in cases of COPD exacerbation?
    Çoban Ağca M; Aksoy E; Duman D; Özmen İ; Yıldırım E; Güngör S; Durmuş N; Aka Aktürk Ü; Saltürk C; Tepetam FM; Karakurt Z
    Tuberk Toraks; 2017 Dec; 65(4):282-290. PubMed ID: 29631526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new predictor to determine the exacerbation and treatment of chronic obstructive pulmonary disease: eosinophil/neutrophil ratio.
    Yakar Hİ; Kanbay A
    Tuberk Toraks; 2020 Sep; 68(3):260-267. PubMed ID: 33295724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease.
    Yun JH; Lamb A; Chase R; Singh D; Parker MM; Saferali A; Vestbo J; Tal-Singer R; Castaldi PJ; Silverman EK; Hersh CP;
    J Allergy Clin Immunol; 2018 Jun; 141(6):2037-2047.e10. PubMed ID: 29709670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood Eosinophilia and Its Stability in Hospitalized COPD Exacerbations are Associated with Lower Risk of All-Cause Mortality.
    Zhang Y; Liang LR; Zhang S; Lu Y; Chen YY; Shi HZ; Lin YX
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1123-1134. PubMed ID: 32547000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eosinophil counts in first COPD hospitalizations: a comparison of health service utilization.
    Bélanger M; Couillard S; Courteau J; Larivée P; Poder TG; Carrier N; Girard K; Vézina FA; Vanasse A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3045-3054. PubMed ID: 30319252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophils in COPD Exacerbations Are Associated With Increased Readmissions.
    Couillard S; Larivée P; Courteau J; Vanasse A
    Chest; 2017 Feb; 151(2):366-373. PubMed ID: 27746201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Upon-Diagnosis Blood Eosinophilic Count with Frequency and Severity of Annual Exacerbation in Chronic Obstructive Pulmonary Disease: A Prospective Longitudinal Analysis.
    Kiani A; Rahimi F; Afaghi S; Paat M; Varharam M; Dizaji MK; Dastoorpoor M; Abedini A
    Can Respir J; 2023; 2023():8678702. PubMed ID: 37153722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD.
    Negewo NA; McDonald VM; Baines KJ; Wark PA; Simpson JL; Jones PW; Gibson PG
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1495-504. PubMed ID: 27445469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood Eosinophil and Risk of Exacerbation in Chronic Obstructive Pulmonary Disease Patients: A Retrospective Cohort Analysis.
    Chan MC; Yeung YC; Yu ELM; Yu WC
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2869-2877. PubMed ID: 33204083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does eosinophilic COPD exacerbation have a better patient outcome than non-eosinophilic in the intensive care unit?
    Saltürk C; Karakurt Z; Adiguzel N; Kargin F; Sari R; Celik ME; Takir HB; Tuncay E; Sogukpinar O; Ciftaslan N; Mocin O; Gungor G; Oztas S
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1837-46. PubMed ID: 26392758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil to lymphocyte ratio is a better indicator of COPD exacerbation severity in neutrophilic endotypes than eosinophilic endotypes.
    Aksoy E; Karakurt Z; Gungor S; Ocakli B; Ozmen İ; Yildirim E; Tuncay E; Agca MC; Ciftaslan Goksenoglu N; Adigüzel N
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2721-2730. PubMed ID: 30233162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-IL-5 therapies for chronic obstructive pulmonary disease.
    Donovan T; Milan SJ; Wang R; Banchoff E; Bradley P; Crossingham I
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013432. PubMed ID: 33295032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.